Financhill
Buy
74

XERS Quote, Financials, Valuation and Earnings

Last price:
$3.35
Seasonality move :
-18.08%
Day range:
$3.35 - $3.57
52-week range:
$1.69 - $3.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.68x
P/B ratio:
--
Volume:
1.5M
Avg. volume:
1.9M
1-year change:
73.63%
Market cap:
$520.3M
Revenue:
$163.9M
EPS (TTM):
-$0.44

Earnings Data

Next earnings date for XERS
Mar 06
2025
Most recent earnings per share
-$0.11
Missed by $0.03
(Nov 8/2024)
Consensus Estimate
-$0.08
(Nov 8/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

XERS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/06/2025 Q4 $56.7M -- -- -$0.06 --
11/08/2024 Q3 $51.4M $54.3M -$0.11 -$0.08 -$0.03
08/08/2024 Q2 $45.8M $48.1M -$0.10 -$0.09 -$0.01
05/09/2024 Q1 $41.8M $40.6M -$0.14 -$0.11 -$0.03
03/06/2024 Q4 $43.6M $44.4M -$0.09 -$0.09 -$0.00
11/09/2023 Q3 -- -- -$0.09 -$0.11 $0.02
08/08/2023 Q2 -- -- -$0.14 -$0.11 -$0.03
05/09/2023 Q1 -- -- -$0.12 -$0.15 $0.03
03/08/2023 Q4 -- -- -$0.10 -$0.15 $0.05
11/09/2022 Q3 -- -- -$0.16 -$0.16 -$0.01
08/10/2022 Q2 -- -- -$0.19 -$0.22 $0.03
05/11/2022 Q1 -- -- -$0.25 -- --
03/10/2022 Q4 -- -- -$0.42 -- --
11/10/2021 Q3 -- -- -$0.39 -- --
08/05/2021 Q2 -- -- -$0.41 -- --
05/13/2021 Q1 -- -- -$0.30 -- --
03/09/2021 Q4 -- -- -$0.41 -- --
11/09/2020 Q3 -- -- -$0.35 -- --
08/10/2020 Q2 -- -- -$0.63 -- --
05/07/2020 Q1 -- -- -$0.89 -- --
03/11/2020 Q4 -- -- -$1.23 -- --
11/07/2019 Q3 -- -- -$1.22 -- --
08/06/2019 Q2 -- -- -$1.28 -- --
05/09/2019 Q1 -- -- -$1.07 -- --
03/06/2019 Q4 -- -- -$0.98 -- --
11/07/2018 Q3 -- -- -$0.71 -- --
08/13/2018 Q2 -- -- -$3.07 -- --
03/31/2018 Q1 -- -- -$5.49 -- --
12/31/2017 Q4 -- -- -$4.22 -- --
09/30/2017 Q3 -- -- -$3.47 -- --
06/30/2017 Q2 -- -- -$2.41 -- --
03/31/2017 Q1 -- -- -$2.14 -- --

Xeris Biopharma Holdings Earnings Questions

  • How Much did Xeris Biopharma Holdings Generate in Revenue Last Quarter?

    Xeris Biopharma Holdings reported $54.3M worth of top line sales in its most recent quarter.

  • Did Xeris Biopharma Holdings Beat Earnings Last Quarter?

    Xeris Biopharma Holdings announced earnings per share of -$0.11 which represents a miss of analyst forecast a -$0.08 per share.

  • Is Xeris Biopharma Holdings Profitable?

    Xeris Biopharma Holdings reported $40.7M that represents $0.27 per share over the last quarter.

  • What is the Analyst Consensus for Xeris Biopharma Holdings EPS Next Year?

    Xeris Biopharma Holdings's earnings are forecast to decrease from -$0.45 per share to -$0.39 per share next year representing a decrease of -42.22%.

  • When is Xeris Biopharma Holdings's Earnings Date?

    Xeris Biopharma Holdings's next earnings date is March 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 2.13% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.91% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock